Company · CIK 0001650664 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
Editas Medicine, Inc. · EDIT
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 3, 2026 SForm 4 → | Sep 4, 4:27 pm EDT | Linda BurklyEVP, CHIEF SCIENTIFIC OFFICER | 709 | $3.04 | $2,153 | 61,660 | −1.14% | 10b5-1 |
| Sep 3, 2026 SForm 4 → | Sep 4, 4:25 pm EDT | Amy ParisonSVP, Chief Financial Officer | 453 | $3.04 | $1,376 | 13,839 | −3.17% | 10b5-1 |
| Sep 3, 2026 SForm 4 → | Sep 4, 4:22 pm EDT | Gilmore Neil O'NeillCEO, Director | 5,124 | $3.04 | $15,563 | 243,189 | −2.06% | 10b5-1 |
| Aug 3, 2026 SForm 4 → | Aug 5, 4:07 pm EDT | Amy ParisonSVP, Chief Financial Officer | 678 | $2.58 | $1,749 | 14,292 | −4.53% | 10b5-1 |
| Jul 28, 2026 SForm 4 → | Jul 29, 4:51 pm EDT | Linda BurklyEVP, CHIEF SCIENTIFIC OFFICER | 4,928 | $2.67 | $13,158 | 62,369 | −7.32% | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 8, 2026 AForm 4 → | Sep 9, 4:58 pm EDT | Daniel Scott OryEVP, Chief Medical Officer | 950,000 | — | — | 950,000 | — | |
| Aug 6, 2026 AForm 4 → | Aug 7, 5:16 pm EDT | Patrick Thomas Ellinor IIDirector | 103,400 | — | — | 103,400 | — |